Characteristics | In-hospital mortality | Survival of hospital | p-value |
---|---|---|---|
Patients | N = 65 | N = 343 |  |
Demographics | |||
Age | 79 (71–87) | 72 (60–80) |  < 0.001 |
Sex m (male) f (female) | m 21 (32%) f 44 (68%) | m 167 (49%) f 176 (51%) | 0.015 |
Premorbid mRS | 4 (2 –4) | 3 (1–4) | 0.004 |
Comorbidities | |||
Charlson Comorbidity Index | 4 (3–6) | 3 (1–4) |  < 0.001 |
Diabetes mellitus | 26 (40%) | 107 (31%) | 0.165 |
Insulin-dependent diabetes mellitus | 7 (11%) | 48 (14%) | 0.511 |
Status epilepticus (SE) | |||
STESS ≥ 3 | 60 (92%) | 212 (62%) |  < 0.001 |
Etiology of SE | |||
Potentially fatal etiology | 44 (68%) | 82 (24%) |  < 0.001 |
Treatment with VPA | |||
VPA single infusion* | 2 (3%) | 40 (12%) | 0.037 |
VPA repeated or continuous infusion | 63 (97%) | 303 (88%) | 0.037 |
In-hospital complications | |||
Need for mechanical ventilation | 37 (57%) | 143 (42%) | 0.023 |
Episodes of hypoglycemia* | 3 (5%) | 9 (3%) | 0.416 |
Bleeding with intervention* | 2 (3%) | 18 (5%) | 0.753 |